BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wong G, Kobinger GP. Backs against the wall: novel and existing strategies used during the 2014-2015 Ebola virus outbreak. Clin Microbiol Rev 2015;28:593-601. [PMID: 25972518 DOI: 10.1128/CMR.00014-15] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Shtanko O, Reyes AN, Jackson WT, Davey RA. Autophagy-Associated Proteins Control Ebola Virus Internalization Into Host Cells. J Infect Dis 2018;218:S346-54. [PMID: 29947774 DOI: 10.1093/infdis/jiy294] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
2 Mwangi W, de Figueiredo P, Criscitiello MF. One Health: Addressing Global Challenges at the Nexus of Human, Animal, and Environmental Health. PLoS Pathog 2016;12:e1005731. [PMID: 27631500 DOI: 10.1371/journal.ppat.1005731] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
3 Zheng X, Wong G, Zhao Y, Wang H, He S, Bi Y, Chen W, Jin H, Gai W, Chu D, Cao Z, Wang C, Fan Q, Chi H, Gao Y, Wang T, Feng N, Yan F, Huang G, Zheng Y, Li N, Li Y, Qian J, Zou Y, Kobinger G, Gao GF, Qiu X, Yang S, Xia X. Treatment with hyperimmune equine immunoglobulin or immunoglobulin fragments completely protects rodents from Ebola virus infection. Sci Rep 2016;6:24179. [PMID: 27067649 DOI: 10.1038/srep24179] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
4 Schmidt R, Beltzig LC, Sawatsky B, Dolnik O, Dietzel E, Krähling V, Volz A, Sutter G, Becker S, von Messling V. Generation of therapeutic antisera for emerging viral infections. NPJ Vaccines 2018;3:42. [PMID: 30323953 DOI: 10.1038/s41541-018-0082-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Wojda TR, Valenza PL, Cornejo K, McGinley T, Galwankar SC, Kelkar D, Sharpe RP, Papadimos TJ, Stawicki SP. The Ebola Outbreak of 2014-2015: From Coordinated Multilateral Action to Effective Disease Containment, Vaccine Development, and Beyond. J Glob Infect Dis 2015;7:127-38. [PMID: 26752867 DOI: 10.4103/0974-777X.170495] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
6 Cooper CL, Martins KA, Stronsky SM, Langan DP, Steffens J, Van Tongeren S, Bavari S. T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protection. Emerg Microbes Infect 2017;6:e46. [PMID: 28588288 DOI: 10.1038/emi.2017.31] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
7 Qiu X, Audet J, Lv M, He S, Wong G, Wei H, Luo L, Fernando L, Kroeker A, Fausther Bovendo H, Bello A, Li F, Ye P, Jacobs M, Ippolito G, Saphire EO, Bi S, Shen B, Gao GF, Zeitlin L, Feng J, Zhang B, Kobinger GP. Two-mAb cocktail protects macaques against the Makona variant of Ebola virus. Sci Transl Med 2016;8:329ra33. [PMID: 26962157 DOI: 10.1126/scitranslmed.aad9875] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 10.0] [Reference Citation Analysis]
8 Qiu X, Kroeker A, He S, Kozak R, Audet J, Mbikay M, Chrétien M. Prophylactic Efficacy of Quercetin 3-β-O-d-Glucoside against Ebola Virus Infection. Antimicrob Agents Chemother 2016;60:5182-8. [PMID: 27297486 DOI: 10.1128/AAC.00307-16] [Cited by in Crossref: 38] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
9 Wec AZ, Herbert AS, Murin CD, Nyakatura EK, Abelson DM, Fels JM, He S, James RM, de La Vega MA, Zhu W, Bakken RR, Goodwin E, Turner HL, Jangra RK, Zeitlin L, Qiu X, Lai JR, Walker LM, Ward AB, Dye JM, Chandran K, Bornholdt ZA. Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses. Cell 2017;169:878-890.e15. [PMID: 28525755 DOI: 10.1016/j.cell.2017.04.037] [Cited by in Crossref: 107] [Cited by in F6Publishing: 96] [Article Influence: 21.4] [Reference Citation Analysis]
10 Wang H, Wong G, Zhu W, He S, Zhao Y, Yan F, Rahim MN, Bi Y, Zhang Z, Cheng K, Jin H, Cao Z, Zheng X, Gai W, Bai J, Chen W, Zou Y, Gao Y, Gao GF, Yang S, Xia X, Qiu X. Equine-Origin Immunoglobulin Fragments Protect Nonhuman Primates from Ebola Virus Disease. J Virol 2019;93:e01548-18. [PMID: 30541860 DOI: 10.1128/JVI.01548-18] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
11 Hawiger J, Veach RA, Zienkiewicz J. New paradigms in sepsis: from prevention to protection of failing microcirculation. J Thromb Haemost 2015;13:1743-56. [PMID: 26190521 DOI: 10.1111/jth.13061] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 7.9] [Reference Citation Analysis]
12 Braid LR, Hu WG, Davies JE, Nagata LP. Engineered Mesenchymal Cells Improve Passive Immune Protection Against Lethal Venezuelan Equine Encephalitis Virus Exposure. Stem Cells Transl Med 2016;5:1026-35. [PMID: 27334491 DOI: 10.5966/sctm.2015-0341] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
13 Siragam V, Wong G, Qiu XG. Animal models for filovirus infections. Zool Res 2018;39:15-24. [PMID: 29511141 DOI: 10.24272/j.issn.2095-8137.2017.053] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
14 de La Vega MA, Stein D, Kobinger GP. Ebolavirus Evolution: Past and Present. PLoS Pathog 2015;11:e1005221. [PMID: 26562671 DOI: 10.1371/journal.ppat.1005221] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
15 Miller JL, Spiro SG, Dowall SD, Taylor I, Rule A, Alonzi DS, Sayce AC, Wright E, Bentley EM, Thom R, Hall G, Dwek RA, Hewson R, Zitzmann N. Minimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig Model. PLoS One 2016;11:e0167018. [PMID: 27880800 DOI: 10.1371/journal.pone.0167018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
16 Wong G, He S, Siragam V, Bi Y, Mbikay M, Chretien M, Qiu X. Antiviral activity of quercetin-3-β-O-D-glucoside against Zika virus infection. Virol Sin 2017;32:545-7. [PMID: 28884445 DOI: 10.1007/s12250-017-4057-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
17 Zhang X, Rong Y, Sun L, Liu L, Su H, Zhang J, Teng G, Du N, Chen H, Fang Y, Zhan W, Kanu AB, Koroma SM, Jin B, Xu Z, Song H. Prognostic Analysis of Patients with Ebola Virus Disease. PLoS Negl Trop Dis 2015;9:e0004113. [PMID: 26398207 DOI: 10.1371/journal.pntd.0004113] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
18 Long CM, Marzi A. Biodefence research two decades on: worth the investment? Lancet Infect Dis 2021;21:e222-33. [PMID: 34331891 DOI: 10.1016/S1473-3099(21)00382-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Nanbo A, Maruyama J, Imai M, Ujie M, Fujioka Y, Nishide S, Takada A, Ohba Y, Kawaoka Y. Ebola virus requires a host scramblase for externalization of phosphatidylserine on the surface of viral particles. PLoS Pathog 2018;14:e1006848. [PMID: 29338048 DOI: 10.1371/journal.ppat.1006848] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
20 Charlton CL, Hull N, Sloma CR, Bonifas M, Johnson M, Strain AK, Wolford T, Staley S, Perkins C, Razzaque R, Courtney C, Bind EP. How To Prepare for the Unexpected: a Public Health Laboratory Response. Clin Microbiol Rev 2021;34:e00183-20. [PMID: 33980686 DOI: 10.1128/CMR.00183-20] [Reference Citation Analysis]
21 Nanbo A, Ohba Y. Budding of Ebola Virus Particles Requires the Rab11-Dependent Endocytic Recycling Pathway. J Infect Dis 2018;218:S388-96. [PMID: 30476249 DOI: 10.1093/infdis/jiy460] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
22 Frei JC, Nyakatura EK, Zak SE, Bakken RR, Chandran K, Dye JM, Lai JR. Bispecific Antibody Affords Complete Post-Exposure Protection of Mice from Both Ebola (Zaire) and Sudan Viruses. Sci Rep 2016;6:19193. [PMID: 26758505 DOI: 10.1038/srep19193] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
23 Kieh MD, Cho EM, Myles IA. Contrasting academic and lay press print coverage of the 2013-2016 Ebola Virus Disease outbreak. PLoS One 2017;12:e0179356. [PMID: 28640889 DOI: 10.1371/journal.pone.0179356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]